银屑病患者血清同型半胱氨酸、叶酸和维生素B12水平的系统评价与Meta分析
该系统评价与Meta分析检索截至2018年2月15日的在线数据库,纳入24项比较银屑病患者与对照者血清同型半胱氨酸、叶酸和维生素B12水平的研究。银屑病患者血清同型半胱氨酸水平显著更高(SMD 0.41,95%CI 0.21-0.61;I²=76.7%,18项研究),高同型半胱氨酸血症患病率更高(OR 3.48,95%CI 2.08-5.83;I²=41.1%,7项研究),血清叶酸水平更低(SMD -0.94,95%CI -1.49至-0.40;I²=95.6%,14项研究);血清维生素B12水平两组无差异(SMD 0.004,95%CI -0.49至0.50;I²=92%,11项研究)。
要点
- 银屑病患者血清同型半胱氨酸水平较对照者显著升高(SMD 0.41,95%CI 0.21-0.61)。
- 银屑病患者高同型半胱氨酸血症患病率较对照者显著升高(OR 3.48,95%CI 2.08-5.83)。
- 银屑病患者血清叶酸水平较对照者显著降低(SMD -0.94,95%CI -1.49至-0.40);维生素B12两组无差异。
核心结论
- 银屑病患者可能较无银屑病的对照者血清同型半胱氨酸水平更高、叶酸水平更低,但鉴于存在显著异质性及其他局限性,这些关联需在更多研究中进一步检验。
研究设计与样本
- 系统评价与Meta分析,检索在线数据库截至2018年2月15日,纳入24项比较银屑病患者与对照者血清同型半胱氨酸、叶酸和维生素B12水平的研究。
- 采用随机效应模型估计二分类数据的比值比和连续数据的标准化均数差(SMD)。
主要发现
- 银屑病患者较对照者血清同型半胱氨酸水平显著更高(SMD 0.41,95%CI 0.21-0.61;I²=76.7%,18项研究)。
- 银屑病患者较对照者高同型半胱氨酸血症患病率更高(OR 3.48,95%CI 2.08-5.83;I²=41.1%,7项研究)。
- 银屑病患者较对照者血清叶酸水平显著更低(SMD -0.94,95%CI -1.49至-0.40;I²=95.6%,14项研究)。
- 银屑病患者与对照者血清维生素B12水平无差异(SMD 0.004,95%CI -0.49至0.50;I²=92%,11项研究)。
- Meta回归分析显示同型半胱氨酸水平的SMD与叶酸水平的SMD呈显著负相关。
关键数值与推荐
- 血清同型半胱氨酸水平:银屑病患者较对照者SMD 0.41(95%CI 0.21-0.61;I²=76.7%,18项研究)。
- 高同型半胱氨酸血症患病率:银屑病患者较对照者OR 3.48(95%CI 2.08-5.83;I²=41.1%,7项研究)。
- 血清叶酸水平:银屑病患者较对照者SMD -0.94(95%CI -1.49至-0.40;I²=95.6%,14项研究)。
- 血清维生素B12水平:银屑病患者与对照者SMD 0.004(95%CI -0.49至0.50;I²=92%,11项研究),无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 存在显著异质性:同型半胱氨酸I²=76.7%,高同型半胱氨酸血症I²=41.1%,叶酸I²=95.6%,维生素B12 I²=92%。
- 原文述及其他局限性,这些关联需在更多研究中进一步检验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with psoriasis are at increased risk for cardiovascular comorbidities. Previous studies examined the possible contribution of serum homocysteine, folate and vitamin B12 to cardiovascular risks in patients with psoriasis but had conflicting conclusions. OBJECTIVES: To perform a systematic review and meta-analysis of studies on serum homocysteine, folate and vitamin B12 levels in patients with psoriasis. METHODS: Online databases were searched on 15 February 2018 to include studies comparing serum homocysteine, folate and vitamin B12 levels between patients with psoriasis and controls. A random effects model was adopted to estimate odds ratios for dichotomous data and standardized mean differences (SMDs) for continuous data. RESULTS: A comprehensive literature search identified 24 studies eligible for inclusion. Compared with controls, patients with psoriasis had a significantly higher serum homocysteine level [SMD 0·41, 95% confidence interval (CI) 0·21-0·61; I2 = 76·7%, 18 studies], a higher prevalence of hyperhomocysteinaemia (odds ratio 3·48, 95% CI 2·08-5·83; I2 = 41·1%, seven studies) and a lower serum folate level (SMD -0·94, 95% CI -1·49 to -0·40; I2 = 95·6%, 14 studies). However, there was no difference in serum vitamin B12 levels between patients with psoriasis and the control group (SMD 0·004, 95% CI -0·49 to 0·50; I2 = 92%, 11 studies). Metaregression analysis revealed a significant inverse correlation between the SMD of homocysteine levels and folate levels. CONCLUSIONS: Patients with psoriasis might have higher serum homocysteine and lower folate levels than control patients without psoriasis. However, due to significant heterogeneity and other limitations, the associations require further examinations in more studies.
引用
- Tsai TY, Yen H, Huang YC, et al. Serum homocysteine, folate and vitamin B12 levels in patients with psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2018. PMID: 30074615. doi:10.1111/bjd.17034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。